Federal Rescheduling of Marijuana to Schedule 3 Opens $50 Billion Industry to Mainstream Capital

What’s happening

The federal government has moved marijuana from Schedule 1 to Schedule 3, removing a major regulatory barrier and unlocking access to banking, institutional investment, and interstate commerce for the legal cannabis industry. The $50 billion market is now positioned for rapid consolidation and mainstream corporate entry.

Market impact

Cannabis ETFs and publicly traded operators (Tilray, Canopy Growth, Curaleaf) should see valuation re-rating as institutional capital becomes available and banking access normalizes. Expect M&A activity and entry by large CPG and pharmaceutical companies seeking exposure to a maturing consumer category.

Broader implications

Rescheduling removes a key political and regulatory overhang that has constrained the industry for years. This accelerates normalization of cannabis as a consumer product and opens the door for federal tax reform and interstate licensing frameworks, fundamentally reshaping the competitive landscape.